Inventor · disambiguated record
Nicholas Mitsiades
Also filed as: MITSIADES NICHOLAS · MITSIADES NICHOLAS S
6 granted patents·5 pending applications·14 citations·filing 2004–2021
73Inventor score
Files withDANA FARBER CANCER INST INC4BAYLOR COLLEGE MEDICINE3ANDERSON KENNETH C2BRISTOL MYERS SQUIBB CO1DANA FABER CANCER INST INC1
Top patents by PatentIndex Score
11 records- 0177US7381703B2Aplidine for multiple myeloma treatmentDANA FABER CANCER INST INC·Filed 2004·Granted Jun 3, 2008·12 cites·3 claims
- 0267US8466147B2Use of reversine and analogs for treatment of cancerANDERSON KENNETH C·Filed 2007·Granted Jun 18, 2013·2 cites·28 claims
- 0357US2013274142A1Cell Co-Culture Systems and Uses ThereofDANA FARBER CANCER INST INC·Filed 2013·Application pending·0 cites
- 0457US2019011433A1Cell co-culture systems and uses thereofDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
- 0554US10227656B2Diagnostic/prognostic marker and therapeutic target for cancerBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Mar 12, 2019·0 cites·6 claims
- 0654US2010255999A1Cell Co-Culture Systems and Uses ThereofDANA FARBER CANCER INST INC·Filed 2008·Application pending·0 cites
- 0753US8026230B2Methods and compositions for treating cancer using proteasome inhibitorsDANA FARBER CANCER INST INC·Filed 2005·Granted Sep 27, 2011·0 cites·18 claims
- 0850US8685954B2Methods and compositions for treating cancer using proteasome inhibitorsANDERSON KENNETH C·Filed 2011·Granted Apr 1, 2014·0 cites·20 claims
- 0950US2010286090A1Treatment of Multiple MyelomaBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 1049US2023167101A1Novel inhibitors of histone acetyltransferase p300/cbp for cancer therapyBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 1132US10082510B2SRC-2 use as metabolic biomarker for diagnosis and treatment of metastatic prostate cancerBAYLOR COLLEGE MEDICINE·Filed 2015·Granted Sep 25, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas Mitsiades files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →